Login
Subscribe
FDA Clears Genetic Modification in Pigs for Biomedicine and Food
FDA Clears Genetic Modification in Pigs for Biomedicine and Food
The decision, which concerns the removal of a sugar molecule on the surface of cells in a line of domestic pigs, marks the first time an approval has been granted for both purposes simultaneously.
The decision, which concerns the removal of a sugar molecule on the surface of cells in a line of domestic pigs, marks the first time an approval has been granted for both purposes simultaneously.
disease & medicine, biotechnology
Image of the Day: Defective Cilia
Amy Schleunes | Apr 7, 2020 | 1 min read
Super-resolution imaging identifies abnormalities in the hair-like protrusions on a cell’s surface and may help facilitate earlier detection of primary ciliary dyskinesia.
Immune Cell Bank Bets on Future CAR T Success
Nicoletta Lanese | Aug 16, 2019 | 6 min read
The company Cell Vault offers to hold consumers’ T cells for later use, but scientists suggest the service would benefit very few users.
FDA Approves Gene Therapy for Spinal Muscular Atrophy
Ashley Yeager | May 27, 2019 | 3 min read
At $2 million for a single dose, Novartis’s Zolgensma is the most expensive medicine to date, but still less expensive over a lifetime than another approved drug for the rare genetic disease.
Two Fungal Species—One Pathogenic, One Benign—Are Actually the Same
Sukanya Charuchandra | Jul 19, 2018 | 3 min read
Under one name the species is used in food fermentation, and under the other it is a drug-resistant cause of yeast infections.